Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, N-0316 Oslo, Norway.
Department of Endocrinology and Metabolism, Odense University Hospital, University of Southern Denmark, DK-5000 Odense, Denmark.
Int J Mol Sci. 2022 Dec 15;23(24):15983. doi: 10.3390/ijms232415983.
The cysteine protease legumain (also known as asparaginyl endopeptidase or δ-secretase) is the only known mammalian asparaginyl endopeptidase and is primarily localized to the endolysosomal system, although it is also found extracellularly as a secreted protein. Legumain is involved in the regulation of diverse biological processes and tissue homeostasis, and in the pathogenesis of various malignant and nonmalignant diseases. In addition to its proteolytic activity that leads to the degradation or activation of different substrates, legumain has also been shown to have a nonproteolytic ligase function. This review summarizes the current knowledge about legumain functions in health and disease, including kidney homeostasis, hematopoietic homeostasis, bone remodeling, cardiovascular and cerebrovascular diseases, fibrosis, aging and senescence, neurodegenerative diseases and cancer. In addition, this review addresses the effects of some marketed drugs on legumain. Expanding our knowledge on legumain will delineate the importance of this enzyme in regulating physiological processes and disease conditions.
半胱氨酸蛋白酶组织蛋白酶 L(也称为天冬酰胺内肽酶或 δ-分泌酶)是唯一已知的哺乳动物天冬酰胺内肽酶,主要定位于内溶酶体系统,尽管它也以外分泌蛋白的形式存在于细胞外。组织蛋白酶 L 参与调节多种生物过程和组织内稳态,并参与各种恶性和非恶性疾病的发病机制。除了导致不同底物降解或激活的蛋白水解活性外,组织蛋白酶 L 还具有非蛋白水解连接酶功能。这篇综述总结了组织蛋白酶 L 在健康和疾病中的功能的最新知识,包括肾脏内稳态、造血内稳态、骨骼重塑、心血管和脑血管疾病、纤维化、衰老和衰老、神经退行性疾病和癌症。此外,本综述还探讨了一些市售药物对组织蛋白酶 L 的影响。扩大我们对组织蛋白酶 L 的认识将阐明该酶在调节生理过程和疾病状况中的重要性。